化学药品与弹性体密封件相容性研究技术指导原则(试行)(国家药监局通告2018年第14号 ...

2023-4-9 18:16| 发布者: 享瑾美| 查看: 1842| 评论: 0

摘要: 本则重点阐述药品与密封件的相容性,旨在指导药品生产企业系统、规范地进行密封件与药品的相容性研究。药品生产企业应基于药品的剂型、给药途径的风险程度及其与密封件发生相互作用的可能性,评估可能的安全性风险, ...


8. 附件

密封件慎用的添加剂品种

商品名称

化学名称或可能含有的物质

CAS #

可能产生的危险物质

备注

硫化剂及硫化促进剂

Diak 1#

六亚甲基二胺氨基甲酸盐

143-06-6

有毒

 

促进剂M

2-MBT)

2-巯基苯并噻唑

149-30-4

亚硝胺

 

促进剂DM

2,2'-二硫代二苯并噻唑

120-78-5

分解成2-巯基苯并噻唑

 

硫化剂HVA-2

N,N-间苯撑双马来酰亚胺

3006-93-7

有致癌性

 

促进剂BZ

二正丁基二硫代氨基甲酸锌

136-23-2

亚硝胺类化合物

 

促进剂EZ

二乙基二硫代氨基甲酸锌

136-94-7

亚硝胺类化合物

 

促进剂PZ

二甲基二硫代氨基甲酸锌

137-30-4

亚硝胺类化合物

 

促进剂DTDM

4,4-二硫代二吗啉

103-34-4

有毒

 

促进剂TT

二硫代四甲基秋兰姆

137-26-8

易喷出、挥发性亚硝胺

 

其他

炉法炭黑

C

1333-86-4

含多环芳烃类物质

 

 

9. 参考资料

1)化学药品注射剂与塑料包装材料相容性研究技术指导原则(试行)国食药监注〔2012〕267号

2)化学药品注射剂与药用玻璃包装容器相容性研究技术指导原则(试行)(国家食品药品监督管理总局通告2015年第40号

3)《中华人民共和国药典》2015年版 通则9621、9622

4)YBB00142002-2015药品包装材料与药物相容性试验指导原则

5)ICH M7 (R1) Assessment and Control of DNA Reactive (Mutagenic) Impurities in Pharmaceuticals to Limit Potential Carcinogenic Risk.

6)ICH Q3D Guideline for Elemental Impurities.

7)EMEA Guideline on Plastic Immediate Packaging Materials. (2005)

8)European Pharmacopoeia (Ph.Eur) Chapter 3 “Materials and Containers”.

9)United States Pharmacopeia (USP) Chapter 87, 88, 381, 1381, 1663, 1664.

10)Safety Thresholds and Best Practices for Extractables and Leachables in Orally Inhaled and Nasal Drug Products, PQRI Leachables and Extractables Working Group. (2006)

11)Comprehensive Determination of Extractables from Five Different Brands of Stoppers Used for Injectable Products. PDA Journal of Pharmaceutical Science and Technology 2009, 63 527-536.

12)Experimental Protocol for Qualitative Controlled Extraction Studies on Material Test Articles Representative of Prefilled Syringe (PFS) and Small Volume Parenteral (SVP) Container Closure Systems. PQRI Parenteral and Ophthalmic Drug Products Leachables and Extractables Working Group.(2011)

13)Perspectives on the PQRI Extractables and Leachables ''Safety Thresholds and Best Practices'' Recommendations for Inhalation Drug Products. PDA Journal of Pharmaceutical Science and Technology 2013, 67 413-429.

14)The Product Quality Research Institute (PQRI) Leachables and Extractables Working Group Initiatives for Parenteral and Ophthalmic Drug Product (PODP) . PDA Journal of Pharmaceutical Science and Technology 2013, 67 430-447.

15)Extractables Characterization for Five Materials of Construction Representative of Packaging Systems Used for Parenteral and Ophthalmic Drug Products. PDA Journal of Pharmaceutical Science and Technology 2013, 67 448-511.

16)Simulated Leaching (Migration) Study for a Model Container-closure System Applicable to Parenteral and Ophthalmic Drug Products (PODPs). PDA Journal of Pharmaceutical Science and Technology 2016, 70 1-46.

17)Jenke, D. Compatibility of Pharmaceutical Products and Contact Materials. Safety Considerations Associated with Extractables and Leachables. Hoboken, NJ. John Wiley & Sons. 2009.

18)Ball, Douglas J., Norwood, Daniel L., Stults, Cheryl L.M., Nagao, Lee M., ed.

Leachables and Extractables Handbook: Safety Evaluation, Qualification, and Best Practices Applied to Inhalation Drug Products. Hoboken, NJ. John Wiley & Sons. 2012.

123456789

路过

雷人

握手

鲜花

鸡蛋


本站信息仅供参考,不能作为诊断医疗依据,所提供文字图片视频等信息旨在参考交流,如有转载引用涉及到侵犯知识产权等问题,请第一时间联系我们处理

在线客服|关于我们|移动客户端 | 手机版|电子书籍下载|中医启疾光网 (鄂ICP备20008850号 )

Powered by Discuz! X3.5 © 2001-2013 Comsenz Inc. Designed by zyqjg.com

版权

返回顶部